HA, A., EM, E., NMM, J., N, H., AS, S., RA, A., . . . GE, E. (2026). Alpha‑lipoic acid-loaded chitosan nanoparticles ameliorate streptozotocin‑induced diabetic liver injury via Nrf2/HO‑1 activation and TLR4/NF‑κB and JAK2/STAT1 inhibition. Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-026-05521-4
Chicago Style (17th ed.) CitationHA, Abdalla, Elmorsy EM, Jawad NMM, Hosny N, Shams AS, Ayaz RA, Fawzy MS, and Elshopakey GE. "Alpha‑lipoic Acid-loaded Chitosan Nanoparticles Ameliorate Streptozotocin‑induced Diabetic Liver Injury via Nrf2/HO‑1 Activation and TLR4/NF‑κB and JAK2/STAT1 Inhibition." Naunyn-Schmiedeberg's Archives of Pharmacology 2026. https://doi.org/10.1007/s00210-026-05521-4.
MLA (9th ed.) CitationHA, Abdalla, et al. "Alpha‑lipoic Acid-loaded Chitosan Nanoparticles Ameliorate Streptozotocin‑induced Diabetic Liver Injury via Nrf2/HO‑1 Activation and TLR4/NF‑κB and JAK2/STAT1 Inhibition." Naunyn-Schmiedeberg's Archives of Pharmacology, 2026, https://doi.org/10.1007/s00210-026-05521-4.